This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (9)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Topic Collections  • Nutritional and Metabolic Disorders  • Metabolic Diseases  • Cardiovascular System  • Cardiovascular Disease/ Myocardial Infarction  • Alert me on articles by topic  Social Bookmarking   What's this?

Commentary by Priya Kohli, MD; Philip Greenland, MD

JAMA. 2006;295(7):819-821.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

ARCHIVES OF INTERNAL MEDICINE

Metabolic Syndrome vs Framingham Risk Score for Prediction of Coronary Heart Disease, Stroke, and Type 2 Diabetes Mellitus

S. Goya Wannamethee, PhD; A. Gerald Shaper, FRCP; Lucy Lennon, MSc; Richard W. Morris, PhD

Background: We sought to compare metabolic syndrome (MetS) with the Framingham Risk Score (FRS) as predictors of coronary heart disease (CHD), stroke, and type 2 diabetes mellitus (DM2) in middle-aged men.

Methods: A prospective study of 5128 men aged 40 to 59 years with no history of cardiovascular disease (CVD) (CHD or stroke) or DM2 drawn from general practices in 24 British towns and observed for 20 years. Metabolic syndrome was defined as the presence of 3 or more metabolic abnormalities based on modified National Cholesterol Education Program criteria.

Results: Men with MetS at baseline (26%) showed significantly higher relative risk (RR) than men without . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

RELATED ARTICLES

The Metabolic Syndrome
Janet M. Torpy, Cassio Lynm, and Richard M. Glass
JAMA. 2006;295(7):850.
EXTRACT | FULL TEXT  

Metabolic Syndrome vs Framingham Risk Score for Prediction of Coronary Heart Disease, Stroke, and Type 2 Diabetes Mellitus
S. Goya Wannamethee, A. Gerald Shaper, Lucy Lennon, and Richard W. Morris
Arch Intern Med. 2005;165(22):2644-2650.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Insulin Resistance, Metabolic Syndrome, and Subclinical Atherosclerosis: The Multi-Ethnic Study of Atherosclerosis (MESA)
Bertoni et al.
Diabetes Care 2007;30:2951-2956.
ABSTRACT | FULL TEXT  

Metabolic Syndrome: Is It a Syndrome? Does It Matter?
Kahn
Circulation 2007;115:1806-1811.
FULL TEXT  

Plasma Aldosterone Is Independently Associated With the Metabolic Syndrome
Bochud et al.
Hypertension 2006;48:239-245.
ABSTRACT | FULL TEXT  

The Metabolic Syndrome (Emperor) Wears No Clothes
Kahn
Diabetes Care 2006;29:1693-1696.
FULL TEXT